Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral

publication of the final appraisal document. 4.3 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within the period set out in the paragraphs above. This means that, if a patient has coronary artery disease or symptomatic peripheral artery disease and the healthcare professional responsible for their care thinks that rivaroxaban plus aspirin is the right treatment, it should be available for use, in line with NICE's recommendations.
